Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 14, 2023
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
Thu, July 13, 2023
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
William Plovanic Maintained (ANGO) at Strong Buy with Increased Target to $20 on, Jul 13th, 2023
William Plovanic of Canaccord Genuity, Maintained "AngioDynamics, Inc." (ANGO) at Strong Buy with Increased Target from $18 to $20 on, Jul 13th, 2023.
William has made no other calls on ANGO in the last 4 months.
There is 1 other peer that has a rating on ANGO. Out of the 1 peers that are also analyzing ANGO, 0 agree with William's Rating of Hold.
This is the rating of the analyst that currently disagrees with William
- Jayson Bedford of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $13 on, Monday, April 17th, 2023
